Sensitive HPV genotyping based on the flow-through hybridization and gene chip

Area of Science:

• Oncology
• Virology
• Molecular Diagnostics

Background:

• Persistent high-risk human papillomavirus (HPV) infection is the primary cause of cervical carcinoma.
• Accurate HPV detection and genotyping are crucial for effective cervical cancer screening programs.

Purpose of the Study:

• To evaluate the efficacy of the HybriMax gene chip method for HPV genotyping.
• To compare HybriMax performance against established methods like Hybrid Capture II (HC-II) and in situ hybridization (ISH).

Main Methods:

• The study involved 591 women classified into six histological diagnosis groups.
• HPV genotyping was performed using HybriMax and compared with HC-II and ISH results.
• Statistical analysis included calculating the Kappa index (KI) to assess agreement between methods.

Main Results:

• HybriMax demonstrated high overall accordance rates with HC-II (92.5%) and ISH (100% in cancer group).
• Excellent agreement was observed between HybriMax and HC-II, with a high Kappa index (KI) of 0.814.
• The HybriMax method identified common HPV genotypes, with notable differences between patient and normal control groups.

Conclusions:

• The HybriMax gene chip is an efficient and reliable method for HPV genotyping.
• HybriMax is suitable for clinical applications in cervical cancer screening due to its accuracy and efficiency.